How is Oxytocin administered?
This describes how Oxytocin is typically administered in clinical and research references, not a self-administration guide. The usual route is Intranasal (most common) or sub-q, on a 30 min before social context schedule, generally over as-needed, not chronic daily. Specific dosing is individual and beyond general information, and human evidence for Oxytocin is limited.
Administration at a glance (reference data)
- Route: Intranasal (most common) or sub-q
- Schedule: 30 min before social context
- Cycle length: As-needed, not chronic daily
- Half-life: ~3-5 minutes
References
- Intranasal oxytocin for social cognition and anxiety, review — Quintana DS et al., Mol Psychiatry, 2021
- Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder — Sikich L, Kolevzon A, King BH, et al.; New England Journal of Medicine; 2021
- Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial — Yamasue H, Okada T, Munesue T, et al.; Molecular Psychiatry; 2020
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Oxytocin
Last updated 2026-06-15.